ArticleBMJ open diabetes research & care2022

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK.

Tracey Weiss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.